Jonathan S. Stamler, MD

New Capabilities

Leading clinical development of SCoR2 inhibitor

In December 2025, researchers at University Hospitals in Cleveland and Case Western Reserve University reported an enzyme the body needs to build fat, called SCoR2. Blocking it in mice stopped weight gain, protected the liver and lowered bad cholesterol, the team wrote in <em>Science Signaling</em>.

Updated Oct 25